Cardiotonic drugs are a class of medications primarily designed to enhance the contractile force of the heart muscle and improve its pumping efficiency. These drugs play a crucial role in the management of various cardiovascular conditions, particularly heart failure. By increasing the strength of each heartbeat, cardiotonic drugs help improve cardiac output, ensuring that the heart effectively pumps blood throughout the body. Digoxin, a well-known cardiotonic drug, is derived from the foxglove plant and has been used for centuries. It works by inhibiting a sodium-potassium pump, leading to an increase in intracellular calcium concentration, which, in turn, strengthens myocardial contractions. While cardiotonic drugs can be beneficial in certain clinical scenarios, their use requires careful monitoring due to the narrow therapeutic window and potential for toxicity. In modern medicine, these drugs are often prescribed in combination with other cardiovascular medications to optimize treatment outcomes for patients with heart-related conditions.
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China